Subscribe To
IHE / 3 Sector ETFs That Beat The Market Last Week
![3 Sector ETFs That Beat The Market Last Week](https://cdn.snapi.dev/images/v1/j/3/13179-2021966.jpg)
IHE News
![Eli Lilly Beats on Q3 Earnings: ETFs to Buy Eli Lilly Beats on Q3 Earnings: ETFs to Buy](https://cdn.snapi.dev/images/v1/x/k/588-2139574.jpg)
By Zacks Investment Research
November 3, 2023
Eli Lilly Beats on Q3 Earnings: ETFs to Buy
Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug more_horizontal
![Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?](https://cdn.snapi.dev/images/v1/j/d/default19-2096464.jpg)
By Zacks Investment Research
October 10, 2023
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively more_horizontal
![IHE: A Highly Concentrated Portfolio Is Able To Generate Growth Over The Long Run IHE: A Highly Concentrated Portfolio Is Able To Generate Growth Over The Long Run](https://cdn.snapi.dev/images/v1/h/q/image-1413600685-2030224.jpg)
By Seeking Alpha
August 21, 2023
IHE: A Highly Concentrated Portfolio Is Able To Generate Growth Over The Long Run
iShares U.S. Pharmaceuticals ETF invests almost 80 percent of its assets in its top 10 holdings, and 48.5 percent in just two companies: JNJ and LLY. more_horizontal
![Pharma ETF (IHE) Hit a 52-Week High Pharma ETF (IHE) Hit a 52-Week High](https://cdn.snapi.dev/images/v1/z/b/2337-2023447.jpg)
By Zacks Investment Research
August 15, 2023
Pharma ETF (IHE) Hit a 52-Week High
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high. more_horizontal
![3 Sector ETFs That Beat The Market Last Week 3 Sector ETFs That Beat The Market Last Week](https://cdn.snapi.dev/images/v1/j/3/13179-2021966.jpg)
By Zacks Investment Research
August 14, 2023
3 Sector ETFs That Beat The Market Last Week
Wall Street wrapped up the last week with mixed performances. The pharma and energy sectors were the biggest winners last week. more_horizontal
![Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?](https://cdn.snapi.dev/images/v1/y/z/default13-2016903.jpg)
By Zacks Investment Research
August 10, 2023
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively more_horizontal
![Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap](https://cdn.snapi.dev/images/v1/m/w/588-2015054.jpg)
By Zacks Investment Research
August 9, 2023
Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap
Eli Lilly (LLY) experienced its most significant surge in stock prices in over two decades following the release of an impressive second-quarter 2023 more_horizontal
![Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?](https://cdn.snapi.dev/images/v1/a/9/etf35-1901007.jpg)
By Zacks Investment Research
May 22, 2023
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Launched on 05/01/2006, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund designed to provide a broad exposure to more_horizontal